CLIN MICROBIOL INFEC 2020 10.1016/j.cmi.2019.10.012
Early cidofovir administration might be associated with a lower probability of respiratory failure in treating human adenovirus pneumonia: a retrospective cohort study
Ko1, JH; Lim, JU; Choi, JY; Oh, HS; Yoo, H; Jhun, BW; Huh, K; Peck, KR

J CLIN MED 2020 10.3390/jcm9051331
Characteristics of Circulating CD4(+) T Cell Subsets in Patients with Mycobacterium avium Complex Pulmonary Disease
Han1, SA; Ko, Y; Shin, SJ; Jhun, BW

ANN LAB MED 2020 10.3343/alm.2020.40.2.169
Diagnostic Performance of the GENEDIA MTB/NTM Detection Kit for Detecting Mycobacterium tuberculosis and Nontuberculous Mycobacteria With Sputum Specimens
Shin1, S; Yoo, IY; Shim, HJ; Kang, OK; Jhun, BW; Koh, WJ; Huh, HJ; Lee, NY

PLoS One 2020 10.1371/journal.pone.0229299
Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma
Lim1, JH; Choi, JY; Im, Y; Yoo, H; Jhun, BW; Jeong, BH; Park, HY; Lee, K; Kim, H; Kwon, OJ; Han, J; Ahn, MJ; Kim, J; Um, SW

LUNG CANCER 2020 10.1016/j.lungcan.2019.11.021
The utility of endosonography for mediastinal staging of non-small cell lung cancer in patients with radiological N0 disease
Shin1, SH; Jeong, BH; Jhun, BW; Yoo, H; Lee, K; Kim, H; Kwon, OJ; Han, J; Kim, J; Lee, KS; Um, SW

ANTIMICROB AGENTS CH 2020 10.1128/AAC.01787-19
Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease
Moon1, SM; Yoo, IY; Huh, HJ; Lee, NY; Jhun, BW

EUR RESPIR J 2020 10.1183/13993003.00798-2019
Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study
Jhun1, BW; Moon, SM; Jeon, K; Kwon, OJ; Yoo, H; Carriere, KC; Huh, HJ; Lee, NY; Shin, SJ; Daley, CL; Koh, WJ

RESP MED 2020 10.1016/j.rmed.2019.105853
Development of tuberculosis in cancer patients receiving immune checkpoint inhibitors
Im1, Y; Lee, J; Kim, SJ; Koh, WJ; Jhun, BW; Lee, SH

J CLIN MED 2019 10.3390/jcm8111898
Clinical Characteristics and Outcomes of Surgically Resected Solitary Pulmonary Nodules Due to Nontuberculous Mycobacterial Infections
Choi1, Y; Jhun, BW; Kim, J; Huh, HJ; Lee, NY

ANN LAB MED 2019 10.3343/alm.2019.39.6.596
First Isolation of Mycobacterium virginiense From a Human Pulmonary Specimen
Jung1, J; Yoo, IY; Jhun, BW; Koh, WJ; Lee, NY; Huh, HJ

EUR RESPIR J 2019 10.1183/13993003.00811-2019
Final treatment outcomes of delamanid-containing regimens in patients with MDR-/XDR-TB in South Korea
Mok1, J; Kang, H; Koh, WJ; Jhun, BW; Yim, JJ; Kwak, N; Lee, T; Kang, B; Jeon, D

MEDICINE 2019 10.1097/MD.0000000000016826
Computed tomographic findings of macrolide-resistant Mycobacterium massiliense pulmonary disease and changes after antibiotic treatment
Yoon1, HJ; Chung, MJ; Koh, WJ; Jhun, BW; Moon, SM

INFECT GENET EVOL 2019 10.1016/j.meegid.2018.10.003
Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases
Huh1, HJ; Kim, SY; Jhun, BW; Shin, SJ; Koh, WJ

J CLIN MICROBIOL 2019 10.1128/JCM.00516-19
GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance
Huh1, HJ; Kim, SY; Shim, HJ; Kim, DH; Yoo, IY; Kang, OK; Ki, CS; Shin, SY; Jhun, BW; Shin, SJ; Daley, CL; Koh, WJ; Lee, NY

ANTIMICROB AGENTS CH 2019 10.1128/AAC.e00665-19
In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates
Kim1, DH; Jhun, BW; Moon, SM; Kim, SY; Jeon, K; Kwon, OJ; Huh, HJ; Lee, NY; Shin, SJ; Daley, CL; Koh, WJ

EUR RESPIR J 2019 10.1183/13993003.01991-2018
Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis
Kwak1, N; Dalcolmo, MP; Daley, CL; Eather, G; Gayoso, R; Hasegawa, N; Jhun, BW; Koh, WJ; Namkoong, H; Park, J; Thomson, R; van Ingen, J; Zweijpfenning, SMH; Yim, JJ

ANTIMICROB AGENTS CH 2019 10.1128/AAC.02331-18
Species Distribution and Macrolide Susceptibility of Mycobacterium fortuitum Complex Clinical Isolates
Kim1, SY; Moon, SM; Jhun, BW; Kwon, OJ; Huh, HJ; Lee, NY; Lee, SH; Shin, SJ; Kasperbauer, SH; Huitt, GA; Daley, CL; Koh, WJ

EUR RESPIR J 2019 10.1183/13993003.01636-2018
Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease
Moon1, SM; Jhun, BW; Daley, CL; Koh, WJ

DIAGN MICR INFEC DIS 2019 10.1016/j.diagrnicrobio.2018.10.022
Genetic mutations in linezolid-resistant Mycobacterium avium complex and Mycobacterium abscessus clinical isolates
Kim1, SY; Jhun, BW; Moon, SM; Jeon, K; Kwon, OJ; Huh, HJ; Lee, NY; Shin, SJ; Daley, CL; Koh, WJ

RESP MED 2019 10.1016/j.rmed.2019.03.014
Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease
Moon1, SM; Jhun, BW; Baek, SY; Kim, S; Jeon, K; Ko, RE; Shin, SH; Lee, H; Kwon, OJ; Huh, HJ; Ki, CS; Lee, NY; Chung, MJ; Lee, KS; Shin, SJ; Daley, CL; Koh, WJ

EUR J CLIN MICROBIOL 2019 10.1007/s10096-019-03471-9
Prolonged shedding of type 55 human adenovirus in immunocompetent adults with adenoviral respiratory infections
Huh1, K; Kim, I; Jung, J; Lee, JE; Jhun, BW; Gu, SH; Song, DH; Lee, EY; Jeong, HJ; Yoo, H

EMERG INFECT DIS 2019 10.3201/eid2503.181597
Epidemiology of Nontuberculous Mycobacterial Infection, South Korea, 2007-2016
Lee1, H; Myung, W; Koh, WJ; Moon, SM; Jhun, BW

RESP MED 2019 10.1016/j.rmed.2019.01.012
Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease
Moon1, SM; Choe, J; Jhun, BW; Jeon, K; Kwon, OJ; Huh, HJ; Lee, NY; Daley, CL; Koh, WJ

DIAGN MICR INFEC DIS 2019 10.1016/j.diagmicrobio.2018.08.008
Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens
Cho1, EH; Huh, HJ; Song, DJ; Lee, SH; Kim, CK; Shin, SY; Ki, CS; Jhun, BW; Moon, SM; Kwon, OJ; Koh, WJ; Lee, NY

TRIALS 2019 10.1186/s13063-018-3053-1
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
Lee1, M; Mok, J; Kim, DK; Shim, TS; Koh, WJ; Jeon, D; Lee, T; Lee, SH; Kim, JS; Park, JS; Lee, JY; Kim, SY; Lee, JH; Jo, KW; Jhun, BW; Kang, YA; Ahn, JH; Kim, CK; Shin, S; Song, T; Shin, SJ; Kim, YR; Ahn, H; Hahn, S; Won, HJ; Jang, JY; Cho, SN; Yim, JJ

RESP MED 2019 10.1016/j.rmed.2018.12.001
Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting
Yoo1, IY; Huh, HJ; Kang, OK; Jhun, BW; Koh, WJ; Lee, NY
외 다수